+
Site Tour

What to Expect on the AV Horizon: Emerging Trials and Future Valve Technologies

Experts reviewed AV valve trials, next-generation transcatheter devices and future strategies improving mitral and tricuspid patient care.

Related Videos

AV VALVES Summit 2026 | Wrap-up

Beyond the guidelines - heart team decision-making

Tricuspid Case Parade - optimizing procedural outcomes

Mitral Case Parade - challenging clinical scenarios

Al and Imaging - transforming patient care

Navigating the VHD guidelines and new evidence

AV VALVES Summit 2026 | Introduction

TRENDING TOPICS

EHRA 2026 | Tutorials | PFA/LAAO

EHRA 2026 | Tutorials | PFA/LAAO proc. by R.TILZ

HFA 2026 | Valves quantification and visualization (E.Donal)

HFA 2026 | Valves quantification and visualization | How to assess an HF patient (E.Donal)

HFA 2026 | How to treat an HF patient with the TEER therapy (E.Donal)

HFA 2026 | Simulation & Hands-on | How to treat an HF patient with the TEER therapy (E.Donal)

CONNEXT


HUB
RELATED RESOURCES

Tri.Fr 2 years outcomes

Navitor 5-years data from CRT

Tendyne expanded clinical study | PCR LV 2025

EXPAND G4 clinical data release | PCR LV 2025

CONNEXT


LIVE
RELATED EVENTS

What to expect on the AV horizon

AV VALVES Summit 2026 | Wrap-up

Beyond the guidelines - heart team decision-making

Tricuspid Case Parade - optimizing procedural outcomes

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline